CEMI - Chembio Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5102.31M
Enterprise Value 3100.04M
Trailing P/E N/A
Forward P/E 1-45.85
PEG Ratio (5 yr expected) 1-0.46
Price/Sales (ttm)3.01
Price/Book (mrq)3.29
Enterprise Value/Revenue 32.94
Enterprise Value/EBITDA 6-11.56

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -29.51%
Operating Margin (ttm)-28.51%

Management Effectiveness

Return on Assets (ttm)-16.31%
Return on Equity (ttm)-36.58%

Income Statement

Revenue (ttm)33.99M
Revenue Per Share (ttm)2.21
Quarterly Revenue Growth (yoy)7.60%
Gross Profit (ttm)3.46M
EBITDA -8.66M
Net Income Avi to Common (ttm)-10.03M
Diluted EPS (ttm)-0.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.37M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)7.33M
Total Debt/Equity (mrq)23.60
Current Ratio (mrq)3.73
Book Value Per Share (mrq)1.81

Cash Flow Statement

Operating Cash Flow (ttm)-14.22M
Levered Free Cash Flow (ttm)-13.36M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.88
52-Week Change 3-45.00%
S&P500 52-Week Change 38.59%
52 Week High 311.55
52 Week Low 34.85
50-Day Moving Average 36.85
200-Day Moving Average 36.53

Share Statistics

Avg Vol (3 month) 366.17k
Avg Vol (10 day) 346.23k
Shares Outstanding 517.17M
Float 13.84M
% Held by Insiders 111.32%
% Held by Institutions 144.94%
Shares Short (May 31, 2019) 488.2k
Short Ratio (May 31, 2019) 42.38
Short % of Float (May 31, 2019) 40.54%
Short % of Shares Outstanding (May 31, 2019) 40.51%
Shares Short (prior month Apr 30, 2019) 470.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 30, 2012